{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:40:10Z","timestamp":1787586010727,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/mt.2016.87","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T07:20:57Z","timestamp":1462260057000},"page":"1187-1198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency"],"prefix":"10.1016","volume":"24","author":[{"given":"Maria","family":"Garcia-Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Garcia-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Benedicenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Kosinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"L\u00f3pez-Manzaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Mar Ma\u00f1u-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Orman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan-LLuis","family":"Vives-Corrons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.87_bib1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3324\/haematol.11469","article-title":"Pyruvate kinase deficiency","volume":"92","author":"Zanella","year":"2007","journal-title":"Haematologica"},{"key":"10.1038\/mt.2016.87_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2141.2006.06076.x","article-title":"Pyruvate kinase deficiency in France: a 3-year study reveals 27 new mutations","volume":"133","author":"Pissard","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2016.87_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/adc.69.5_Spec_No.523","article-title":"Fetal anaemia due to pyruvate kinase deficiency","volume":"69","author":"Gilsanz","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1038\/mt.2016.87_bib4","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood.V95.11.3585","article-title":"Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population","volume":"95","author":"Beutler","year":"2000","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1702576","article-title":"Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency","volume":"26","author":"Tanphaichitr","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/mt.2016.87_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2005.05527.x","article-title":"Red cell pyruvate kinase deficiency: molecular and clinical aspects","volume":"130","author":"Zanella","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2016.87_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3748\/wjg.v11.i8.1241","article-title":"Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia","volume":"11","author":"Hilgard","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1038\/mt.2016.87_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0006-291X(92)91086-6","article-title":"Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells","volume":"188","author":"Kanno","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2016.87_bib9","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1016\/S0021-9258(18)47947-1","article-title":"The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters","volume":"262","author":"Noguchi","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2016.87_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1038\/mt.2016.87_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1038\/mt.2016.87_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-386509-0.00010-7","article-title":"Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy","volume":"507","author":"Cartier","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1038\/mt.2016.87_bib13","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2016.87_bib14","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2016.87_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/mt.2008.259","article-title":"Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin","volume":"17","author":"Pestina","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib16","doi-asserted-by":"crossref","first-page":"e32345","DOI":"10.1371\/journal.pone.0032345","article-title":"Therapeutic hemoglobin levels after gene transfer in \u03b2-thalassemia mice and in hematopoietic cells of \u03b2-thalassemia and sickle cells disease patients","volume":"7","author":"Breda","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.87_bib17","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.V83.8.2305.2305","article-title":"Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency","volume":"83","author":"Tani","year":"1994","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib18","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/mt.2009.200","article-title":"Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme","volume":"17","author":"Meza","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib19","doi-asserted-by":"crossref","first-page":"e45173","DOI":"10.1371\/journal.pone.0045173","article-title":"Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency","volume":"7","author":"Trobridge","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.87_bib20","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood-2003-10-3705","article-title":"Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency","volume":"103","author":"Richard","year":"2004","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib21","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.87_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.87_bib23","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.87_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.87_bib25","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome\u2013long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2016.87_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.gene.6364069","article-title":"Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model","volume":"5","author":"Min-Oo","year":"2004","journal-title":"Genes Immun"},{"key":"10.1038\/mt.2016.87_bib27","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","article-title":"Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection","volume":"117","author":"Biffi","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib28","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1172\/JCI31661","article-title":"Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo","volume":"117","author":"Schwarzwaelder","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.87_bib29","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1172\/JCI31659","article-title":"Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy","volume":"117","author":"Deichmann","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.87_bib30","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/mt.2011.178","article-title":"Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy","volume":"19","author":"Deichmann","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2016.87_bib32","doi-asserted-by":"crossref","first-page":"e24247","DOI":"10.1371\/journal.pone.0024247","article-title":"Analyzing the number of common integration sites of viral vectors\u2013new methods and computer programs","volume":"6","author":"Abel","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.87_bib33","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood.V96.13.4111","article-title":"Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer","volume":"96","author":"Rovira","year":"2000","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib34","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.exphem.2005.07.008","article-title":"Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity","volume":"33","author":"Aizawa","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1038\/mt.2016.87_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ajh.2830190313","article-title":"Molecular aspects of erythroenzymopathies associated with hereditary hemolytic anemia","volume":"19","author":"Miwa","year":"1985","journal-title":"Am J Hematol"},{"key":"10.1038\/mt.2016.87_bib36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.exphem.2007.05.005","article-title":"Glycolytic inhibition by mutation of pyruvate kinase gene increases oxidative stress and causes apoptosis of a pyruvate kinase deficient cell line","volume":"35","author":"Aisaki","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1038\/mt.2016.87_bib37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.V64.3.607.607","article-title":"Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro","volume":"64","author":"Nijhof","year":"1984","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcmd.2007.03.003","article-title":"Pyruvate kinase deficiency: correlation between enzyme activity, extent of hemolytic anemia and protection against malaria in independent mouse mutants","volume":"39","author":"Min-Oo","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1038\/mt.2016.87_bib39","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/mt.2009.134","article-title":"Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis","volume":"17","author":"Kustikova","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/mt.2009.51","article-title":"Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design","volume":"17","author":"Maruggi","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/mt.2011.20","article-title":"Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat \u03b2-thalassemia","volume":"19","author":"Ronen","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib42","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/stem.1406","article-title":"Brief report: impaired cell reprogramming in nonhomologous end joining deficient cells","volume":"31","author":"Molina-Estevez","year":"2013","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2016.87_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2141.2001.02711.x","article-title":"Molecular characterization of the PK-LR gene in sixteen pyruvate kinase-deficient patients","volume":"113","author":"Zanella","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2016.87_bib44","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.cgt.7700225","article-title":"Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors","volume":"7","author":"Gerolami","year":"2000","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2016.87_bib45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mt.2008.5","article-title":"Physiological promoters reduce the genotoxic risk of integrating gene vectors","volume":"16","author":"Zychlinski","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib46","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/mt.2012.110","article-title":"Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene","volume":"20","author":"van Til","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/gt.2009.3","article-title":"Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS","volume":"16","author":"Zanta-Boussif","year":"2009","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.87_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004310051314","article-title":"Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency","volume":"159","author":"Ferreira","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1038\/mt.2016.87_bib49","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1365-2141.2000.02283.x","article-title":"A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency","volume":"110","author":"Manco","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2016.87_bib50","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood-2002-07-2321","article-title":"Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency","volume":"101","author":"van Wijk","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1260","article-title":"Pyruvate kinase deficiency in mice protects against malaria","volume":"35","author":"Min-Oo","year":"2003","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2016.87_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/76095","article-title":"Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences","volume":"25","author":"Follenzi","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2016.87_bib53","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI31807","article-title":"Foxo3 is required for the regulation of oxidative stress in erythropoiesis","volume":"117","author":"Marinkovic","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2016.87_bib54","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V98.12.3261","article-title":"Ineffective erythropoiesis in Stat5a(-\/-)5b(-\/-) mice due to decreased survival of early erythroblasts","volume":"98","author":"Socolovsky","year":"2001","journal-title":"Blood"},{"key":"10.1038\/mt.2016.87_bib55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/gt.2010.163","article-title":"Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction","volume":"18","author":"Charrier","year":"2011","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.87_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ymthe.2006.05.018","article-title":"Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1","volume":"14","author":"Navarro","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.87_bib57","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1021\/ac201267k","article-title":"High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry","volume":"83","author":"Fuhrer","year":"2011","journal-title":"Anal Chem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616303525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:50:43Z","timestamp":1761501043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616303525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1525001616303525"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.87","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2016.87","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}